172 related articles for article (PubMed ID: 11693177)
1. Providing toxicokinetic support for reproductive toxicology studies in pharmaceutical development.
Schwartz S
Arch Toxicol; 2001 Sep; 75(7):381-7. PubMed ID: 11693177
[TBL] [Abstract][Full Text] [Related]
2. Study design and statistical analysis of toxicokinetics: a report of JPMA investigation of case studies.
Igarashi T; Yabe T; Noda K
J Toxicol Sci; 1996 Dec; 21(5):497-504. PubMed ID: 9035061
[TBL] [Abstract][Full Text] [Related]
3. Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies.
Dahlem AM; Allerheiligen SR; Vodicnik MJ
Toxicol Pathol; 1995; 23(2):170-8. PubMed ID: 7569672
[TBL] [Abstract][Full Text] [Related]
4. [Developmental and reproductive toxicology: interest and interpretation].
Stadler J
Therapie; 2014; 69(1):25-30. PubMed ID: 24698185
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic and metabolic studies in the development of drugs].
Vereczkey L
Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
[TBL] [Abstract][Full Text] [Related]
6. Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology.
Roberts SA; Andrews PA; Blanset D; Flagella KM; Gorovits B; Lynch CM; Martin PL; Kramer-Stickland K; Thibault S; Warner G
Regul Toxicol Pharmacol; 2013 Dec; 67(3):382-91. PubMed ID: 24012707
[TBL] [Abstract][Full Text] [Related]
7. Differences between pharmacokinetics and toxicokinetics.
Welling PG
Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
[TBL] [Abstract][Full Text] [Related]
8. Integrating toxicokinetics into toxicology studies and the human health risk assessment process for chemicals: Reduced uncertainty, better health protection.
Claire T; Sean H
Regul Toxicol Pharmacol; 2022 Feb; 128():105092. PubMed ID: 34863906
[TBL] [Abstract][Full Text] [Related]
9. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
[TBL] [Abstract][Full Text] [Related]
10. Opportunities to minimise animal use in pharmaceutical regulatory general toxicology: a cross-company review.
Sparrow SS; Robinson S; Bolam S; Bruce C; Danks A; Everett D; Fulcher S; Hill RE; Palmer H; Scott EW; Chapman KL
Regul Toxicol Pharmacol; 2011 Nov; 61(2):222-9. PubMed ID: 21855593
[TBL] [Abstract][Full Text] [Related]
11. Toxicokinetics in the National Toxicology Program.
Goehl TJ
NIDA Res Monogr; 1997; 173():273-304. PubMed ID: 9260193
[TBL] [Abstract][Full Text] [Related]
12. Regulatory assessment of reproductive toxicology data.
Davidson E
Methods Mol Biol; 2013; 947():489-516. PubMed ID: 23138923
[TBL] [Abstract][Full Text] [Related]
13. Developmental and reproductive toxicology studies in nonhuman primates.
Chellman GJ; Bussiere JL; Makori N; Martin PL; Ooshima Y; Weinbauer GF
Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):446-62. PubMed ID: 20025046
[TBL] [Abstract][Full Text] [Related]
14. Auditing drug metabolism protocols, data, and reports.
Lucas G; Walls S
Qual Assur; 1994 Jun; 3(2):193-7. PubMed ID: 7804636
[TBL] [Abstract][Full Text] [Related]
15. The application of toxicokinetic data to dosage selection in toxicology studies.
Morgan DG; Kelvin AS; Kinter LB; Fish CJ; Kerns WD; Rhodes G
Toxicol Pathol; 1994; 22(2):112-23. PubMed ID: 7973359
[TBL] [Abstract][Full Text] [Related]
16. The way forward in reproductive/developmental toxicity testing.
Spielmann H
Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
[TBL] [Abstract][Full Text] [Related]
17. Evaluations of organ system development in juvenile toxicology testing.
Robinson K
Reprod Toxicol; 2008 Sep; 26(1):51-3. PubMed ID: 18595655
[TBL] [Abstract][Full Text] [Related]
18. The use of toxicokinetic data in preclinical safety assessment: a toxicologic pathologist perspective.
Ploemen JP; Kramer H; Krajnc EI; Martin I
Toxicol Pathol; 2007 Oct; 35(6):836-9. PubMed ID: 17943658
[TBL] [Abstract][Full Text] [Related]
19. The non-GLP toleration/dose range finding study: design and methodology used in an early toxicology screening program.
Herlich JA; Taggart P; Proctor J; Stahle P; Colis R; Hall L; Pugsley MK
Proc West Pharmacol Soc; 2009; 52():94-8. PubMed ID: 22128433
[TBL] [Abstract][Full Text] [Related]
20. Principles and practices of integrating genotoxicity evaluation into routine toxicology studies: a pharmaceutical industry perspective.
Krishna G; Urda G; Theiss J
Environ Mol Mutagen; 1998; 32(2):115-20. PubMed ID: 9776173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
